These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38836841)

  • 21. Blueberry, cranberry, raspberry, and strawberry as modulators of the gut microbiota: target for treatment of gut dysbiosis in chronic kidney disease? From current evidence to future possibilities.
    Coutinho-Wolino KS; Melo MFS; Mota JC; Mafra D; Guimarães JT; Stockler-Pinto MB
    Nutr Rev; 2024 Jan; 82(2):248-261. PubMed ID: 37164634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut Microbiota and Uremic Retention Solutes in Adults With Moderate CKD: A 6-Day Controlled Feeding Study.
    Wiese GN; Biruete A; Stremke ER; Lindemann SR; Jannasch A; Moorthi RN; Moe SM; Swanson KS; Cross TW; Hill Gallant KM
    J Ren Nutr; 2024 Jan; 34(1):26-34. PubMed ID: 37468049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and rationale for an open-label, randomized, controlled pilot trial to evaluate the changes in blood uremic toxins in patients with chronic kidney disease by dietary therapy with sake lees.
    Tokumaru T; Toyama T; Nakade Y; Ogura H; Oshima M; Nakagawa S; Furuichi M; Kitajima S; Sakai N; Shimizu M; Iwata Y; Wada T
    Clin Exp Nephrol; 2024 May; 28(5):440-446. PubMed ID: 38340247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysbiosis-Related Advanced Glycation Endproducts and Trimethylamine N-Oxide in Chronic Kidney Disease.
    Taguchi K; Fukami K; Elias BC; Brooks CR
    Toxins (Basel); 2021 May; 13(5):. PubMed ID: 34069405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Link between gut microbiota dysbiosis and chronic kidney disease.
    Noce A; Marchetti M; Marrone G; Di Renzo L; Di Lauro M; Di Daniele F; Albanese M; Di Daniele N; De Lorenzo A
    Eur Rev Med Pharmacol Sci; 2022 Mar; 26(6):2057-2074. PubMed ID: 35363356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible Effects of Uremic Toxins p-Cresol, Indoxyl Sulfate, p-Cresyl Sulfate on the Development and Progression of Colon Cancer in Patients with Chronic Renal Failure.
    Di Paola R; De A; Izhar R; Abate M; Zappavigna S; Capasso A; Perna AF; La Russa A; Capasso G; Caraglia M; Simeoni M
    Genes (Basel); 2023 Jun; 14(6):. PubMed ID: 37372437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of lactulose on renal function and gut microbiota in adenine-induced chronic kidney disease rats.
    Sueyoshi M; Fukunaga M; Mei M; Nakajima A; Tanaka G; Murase T; Narita Y; Hirata S; Kadowaki D
    Clin Exp Nephrol; 2019 Jul; 23(7):908-919. PubMed ID: 30895529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Fecal Microbiota Transplantation on Composition in Mice with CKD.
    Barba C; Soulage CO; Caggiano G; Glorieux G; Fouque D; Koppe L
    Toxins (Basel); 2020 Nov; 12(12):. PubMed ID: 33255454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression.
    Castillo-Rodriguez E; Fernandez-Prado R; Esteras R; Perez-Gomez MV; Gracia-Iguacel C; Fernandez-Fernandez B; Kanbay M; Tejedor A; Lazaro A; Ruiz-Ortega M; Gonzalez-Parra E; Sanz AB; Ortiz A; Sanchez-Niño MD
    Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 30029499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resistant starch alters gut microbiome and metabolomic profiles concurrent with amelioration of chronic kidney disease in rats.
    Kieffer DA; Piccolo BD; Vaziri ND; Liu S; Lau WL; Khazaeli M; Nazertehrani S; Moore ME; Marco ML; Martin RJ; Adams SH
    Am J Physiol Renal Physiol; 2016 May; 310(9):F857-71. PubMed ID: 26841824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
    Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
    Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Homeostasis in the Gut Microbiota in Chronic Kidney Disease.
    Bhargava S; Merckelbach E; Noels H; Vohra A; Jankowski J
    Toxins (Basel); 2022 Sep; 14(10):. PubMed ID: 36287917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oat β-glucan alleviates DSS-induced colitis
    Bai J; Zhao J; Al-Ansi W; Wang J; Xue L; Liu J; Wang Y; Fan M; Qian H; Li Y; Wang L
    Food Funct; 2021 Oct; 12(19):8976-8993. PubMed ID: 34382058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut Microbiota and Their Derived Metabolites, a Search for Potential Targets to Limit Accumulation of Protein-Bound Uremic Toxins in Chronic Kidney Disease.
    Steenbeke M; Valkenburg S; Gryp T; Van Biesen W; Delanghe JR; Speeckaert MM; Glorieux G
    Toxins (Basel); 2021 Nov; 13(11):. PubMed ID: 34822593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbiota modulation by dietary oat beta-glucan prevents steatotic liver disease progression.
    Jaeger JW; Brandt A; Gui W; Yergaliyev T; Hernández-Arriaga A; Muthu MM; Edlund K; Elashy A; Molinaro A; Möckel D; Sarges J; Halibasic E; Trauner M; Kahles F; Rolle-Kampczyk U; Hengstler J; Schneider CV; Lammers T; Marschall HU; von Bergen M; Camarinha-Silva A; Bergheim I; Trautwein C; Schneider KM
    JHEP Rep; 2024 Mar; 6(3):100987. PubMed ID: 38328439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Dietary Fermentable Fiber Inulin Alters the Intestinal Microbiome and Improves Chronic Kidney Disease Mineral-Bone Disorder in a Rat Model of CKD.
    Biruete A; Chen NX; Metzger CE; Srinivasan S; Oâ Neill K; Fallen PB; Fonseca A; Wilson HE; de Loor H; Evenepoel P; Swanson KS; Allen MR; Moe SM
    bioRxiv; 2023 Jan; ():. PubMed ID: 36778372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of Dietary Fiber and Gut Microbiome Modulation in Progression of Chronic Kidney Disease.
    Ranganathan N; Anteyi E
    Toxins (Basel); 2022 Mar; 14(3):. PubMed ID: 35324680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized double-blind cross-over trial to study the effects of resistant starch prebiotic in chronic kidney disease (ReSPECKD).
    Shamloo M; Mollard R; Wang H; Kingra K; Tangri N; MacKay D
    Trials; 2022 Jan; 23(1):72. PubMed ID: 35073986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of dietary fiber on chronic kidney disease： Base on the gut-kidney axis theory.
    Xie X; Dai S; Dai Y; Ning J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Feb; 45(2):193-197. PubMed ID: 32386047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rhubarb Enema Increasing Short-Chain Fatty Acids that Improves the Intestinal Barrier Disruption in CKD May Be Related to the Regulation of Gut Dysbiosis.
    Ji C; Lu F; Wu Y; Lu Z; Mo Y; Han L; Lin Q; Liu X; Zou C
    Biomed Res Int; 2022; 2022():1896781. PubMed ID: 35097110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.